Clinical trials
Follow clinical development from study design and recruitment through results.
- Trial phase
- Status
- Readouts
Drug intelligence / Profile preview
Xiao Yao San is a traditional Chinese medicine (TCM) herbal formula composed of eight herbs: Bupleuri radix (Chai Hu), Angelicae radix (Dang Gui or Dong Quai), Paeoniae radix alba (Bai Shao), Atractylodis rhizome macrocephalae (Bai Zhu), Poria cocos (Fu Ling), Zingiberis siccatum rhizome (Sheng Jiang), Menthae haplocalycis (Bo He), and Glycyrrhizae radix (Gan Cao or Licorice)[1][6]. It has been used since the Song Dynasty for the treatment of depression, anxiety, stress-related disorders[1][3][4], as well as functional gastrointestinal disorders and polycystic ovary syndrome[1]. The formula is believed to harmonize liver qi stagnation with spleen qi deficiency according to TCM theory. Modern studies suggest it may modulate neurotransmitter systems involved in mood regulation and influence metabolic pathways related to glutamate metabolism[4]. Modified forms such as Jia Wei Xiao Yao San add additional herbs for broader indications.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Follow clinical development from study design and recruitment through results.
Explore development by indication, patient population, and geography.
Trace asset ownership, licensing agreements, and commercial partnerships.
Explore the patent landscape and regulatory exclusivity around an asset.
Compare development programs by target, modality, and indication.
Connect source evidence and development news to your research questions.
See how Gosset can support your research on xiao yao san.